MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year. The green ...
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...
This repository contains make file for easy install of the Digilent Adept 2 Runtime and Utilities. The Adept Runtime consists of the shared libraries, firmware images, and configuration files ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback